{
  "docId": "019de076-2049-75e8-9528-894c783c20b2",
  "docSlug": "1f0c6538bd85906c2fdac9c48c149895",
  "documentTitle": "argenx SE | Investor Presentation Deck | 25 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 25,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide outlines a clinical trial protocol with a 1-3 week screening phase followed by a 30-week treatment period.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-2049-75e8-9528-894c783c20b2/15",
  "deckHref": "/decks/019de076-2049-75e8-9528-894c783c20b2",
  "deckJsonHref": "/decks/019de076-2049-75e8-9528-894c783c20b2.json",
  "deckAnchorHref": "/decks/019de076-2049-75e8-9528-894c783c20b2#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.09,
        "w": 0.48,
        "x": 0.26,
        "y": 0.84
      },
      "kind": "callout",
      "text": "Topline data expected around YE 2023",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8cea82f-badf-4283-a04a-d22423a94e28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.94,
        "x": 0.03,
        "y": 0.198
      },
      "kind": "diagram",
      "text": "Screening to Randomization to 30-week treatment",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a9b910d-13a8-4497-92db-85de9f3b6fb7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.18,
        "x": 0.8,
        "y": 0.3
      },
      "kind": "list",
      "text": "Primary endpoint is proportion of PV patients achieving CRmin* within 30 weeks. N=222 (PV and PF). PF patients capped. Followed by Open Label Extension study.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50252af7-1aee-4212-b702-1520afed1352",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.03,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "CR=complete clinical remission; CRmin=complete remission on minimal therapy; EoC=end of consolidation; SC=subcutaneous.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b75e48a-92d8-4766-833f-11164389b332",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pemphigus ADDRESS Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43281447-9f98-4a88-8afd-a2a1543a0083",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 15,
      "from": 13,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "ebeb26eb-b6f0-468f-a72f-dbe5b8c0b96b",
      "evidence": "The presentation provides a timeline of upcoming milestones and launches.",
      "position": 1,
      "objective": "Why is now the right time for argenx SE's products and growth strategy?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}